Pharmhouse Corp (PHSE) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.00x
Pharmhouse Corp (PHSE) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $24.84 Million. Check PHSE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$24.84 Million
USD
Capital Expenditures
$0.00
USD
Pharmhouse Corp Cash Flow Reinvestment Rate (2019–2023)
Historical reinvestment intensity for Pharmhouse Corp across 2 annual periods. Explore PHSE operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Pharmhouse Corp (2019–2023)
Year-by-year capital reinvestment analysis for Pharmhouse Corp. For live market cap and broader valuation context, see PHSE market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.00x | $0.00 | $1.71 Million | $0.00 | — |
| 2019 | 0.00x | $0.00 | $652.00 | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow